Live feed
Filing
SC 13G
SC 13G0001493152-23-009213·Morris Jeffrey Allen
Schedule 13G ownership disclosure
PROVECTUS BIOPHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 74373PB99
Event date: 2023-03-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-23-009213
- Form type
- SC 13G
- Filer
- Morris Jeffrey Allen
- CIK
- CIK 1959175
- Filed
- Mar 28, 2023
- Reporting period
- Mar 27, 2023
- Description
- Schedule 13G beneficial ownership